Bird & Bird advised Nexstim on cooperation and investment agreements with Brainlab

International law firm Bird & Bird has successfully advised Nexstim Plc, a Finnish, globally operating growth-oriented medical technology company, on its cooperation agreement and investment agreement with Brainlab AG, a leading German developer of advanced medical technology solutions.

The cooperation agreement aims at the advancement of non-invasive brain mapping technologies, as well as the distribution of certain Nexstim products by Brainlab in the segment. 

In connection with the cooperation agreement, Brainlab and Nexstim have also agreed on a maximum of EUR 5,095,000 equity investment into Nexstim by Brainlab. 

Bird & Bird’s advisory team, consisting of partners Maria Carlsson, Laura Huomo, and Iina-Mari Supperi, along with Counsel Vuokko Rajamäki and associates Juliana Kliesch, Marla Melin and Rondy Stenman, provided comprehensive legal support for both the cooperation and investment agreements.

News & Deals

More News & Deals
Deal Bird & Bird advises Gulermak Renewables Ltd on the acquisition of a 42.4 MW UK solar project

Jun 18 2025

Read More
News Bird & Bird wins Five Awards at the LMG Life Sciences Awards EMEA 2025

Jun 18 2025

Read More
Deal Bird & Bird advises Hoivatilat Oyj on the purchase of a care facility portfolio

Jun 17 2025

Read More
Deal Bird & Bird advises Aibidia on its $28 million Series B funding round

Jun 17 2025

Read More
Deal Bird & Bird advises PHINIA on cross-border acquisition of SEM

Jun 16 2025

Read More
News Bird & Bird Celebrates 38 Lawyers Named Global Leaders in IAM and WTR 2025 Rankings

Jun 12 2025

Read More